<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0295">
 <label>59</label>
 <element-citation publication-type="journal" id="sbref0295">
  <person-group person-group-type="author">
   <name>
    <surname>Naito</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Izumi</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kodama</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Sakagami</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kajiwara</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Nishikawa</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Watanabe</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Sarafianos</surname>
    <given-names>S.G.</given-names>
   </name>
   <name>
    <surname>Oishi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Fujii</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>SC29EK, a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtide</article-title>
  <source>Antimicrob Agents Chemother</source>
  <volume>53</volume>
  <year>2009</year>
  <fpage>1013</fpage>
  <lpage>1018</lpage>
  <pub-id pub-id-type="pmid">19114674</pub-id>
 </element-citation>
</ref>
